Viridian Therapeutics Inc (NASDAQ:VRDN)’s traded shares stood at 1.83 million during the last session, with the company’s beta value hitting 1.07. At the close of
As the biotechnology business prepares to take part in a significant event, shares of Viridian Therapeutics Inc. (Nasdaq: VRDN) were up 13.64% at $26.00 at
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
